Representative before the EPO

Company dna btg international ltd
no operation time available
3 offices
active in Legal Services

We have observed 1 EP application Matthew William Rodgers has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11757557

TREATMENT OF VASCULAR DISEASES USING ENCAPSULATED CELLS ENCODING AND SECRETING GLP-1, OR A FRAGMENT OR VARIANT THEREOF

IPC classification:
A61K 9/50, C12N 5/0775, A61K 38/18, A61K 38/26
Agent:
Matthew William Rodgers, BTG International Ltd
Agent:
Andreas Stosch, Graf von Stosch Patentanwaltsgesellschaft mbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature